Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Esperion Therapeutics Inc
ESPRCurrent price
1.56 USD
+0.01 USD (+0.65%)
Last closed
1.54 USD
Company
www.esperion.com
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
163 753 920 USD
Yield for 12 month
-79.03 %
Week
Month
Year
ESPR
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Address: 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108
Analytics
WallStreet Target Price
8.25 USDP/E ratio
–Dividend Yield
–Current Year
+75 475 000 USD
Last Year
+78 447 000 USD
Current Quarter
+33 969 000 USD
Last Quarter
+25 786 000 USD
Current Year
+48 508 000 USD
Last Year
+64 230 000 USD
Current Quarter
+20 592 000 USD
Last Quarter
+19 000 000 USD
Key Figures ESPR
1 year
3 years
5 years
10 years
EBITDA
-155 459 008 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-36.44 %
PEG Ratio
-4.78
Return On Equity TTM
-260.79 %
Wall Street Target Price
8.25 USD
Revenue TTM
102 902 000 USD
Book Value
-3.66 USD
Revenue Per Share TTM
1.1 USD
Dividend Share
–
Quarterly Revenue Growth YOY
79 %
Dividend Yield
–
Gross Profit TTM
-70 419 000 USD
Earnings Share
-2.27 USD
Diluted Eps TTM
-2.27 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
-202.51 %
Dividend Analytics ESPR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ESPR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:6
Payout Ratio
–
Last Split Date
11.06.2013
Dividend Date
–
Stock Valuation ESPR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
0.8819
Enterprise Value Revenue
3.0312
Price Sales TTM
1.5914
Enterprise Value EBITDA
-2.0809
Price Book MRQ
98.4236
Financials ESPR
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators ESPR
For 52 weeks
0.7 USD
8.87 USD
50 Day MA
0.98 USD
Shares Short Prior Month
18 218 864
200 Day MA
1.71 USD
Short Ratio
5.39
Shares Short
18 306 254
Short Percent
19.4 %
Google
Apple
Facebook